Öz
Introduction: Malignant tumors of the small intestine comprise 2-3% of all gastrointestinal cancers. Adenocarcinomas account for 95% of primary small intestine malignancies. The prevalence of adenocarcinoma increases with advanced age. They are commonly located in the distal duodenum and the proximal jejunum. They are usually diagnosed coincidentally and are most effectively treated by surgery.
Case Presentation: Here we present a 67-year-old female patient who underwent emergency surgery for acute strangulated hernia during which a tumoral mass was discovered in the ileum, leading to a diagnosis of adenocarcinoma of the ileum.
Conclusion: The most effectively treated method is surgery in small intestine adenocarcinomas.
Anahtar Kelimeler
Kaynakça
- Shenoy S. Primary small-bowel malignancy: update in tumor biology, markers, and management strategies. Journal of gastrointestinal cancer 2014; 45: 421-30.
- Hatzaras I, Palesty JA, Abir F, et al. Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the connecticut tumor registry. Archives of surgery 2007; 142: 229-35.
- Honda W, Ohmiya N, Hirooka Y, et al. Enteroscopic and radiologic diagnoses, treatment, and prognoses of small-bowel tumors. Gastrointestinal endoscopy 2012; 76: 344-54.
- Talamonti MS, Goetz LH, Rao S, Joehl RJ. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Archives of surgery 2002; 137: 564-70; discussion 70-1.
- Howdle PD, Jalal PK, Holmes GK, Houlston RS. Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM : monthly journal of the Association of Physicians 2003; 96: 345-53.
- Reynolds I, Healy P, McNamara DA. Malignant tumours of the small intestine. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 2014; 12: 263-70.
- Cerutti A, Rescigno M. The biology of intestinal immunoglobulin A responses. Immunity 2008; 28: 740-50.
- Sanders LM, Henderson CE, Hong MY, et al. Pro-oxidant environment of the colon compared to the small intestine may contribute to greater cancer susceptibility. Cancer letters 2004; 208: 155-61.
- Aparicio T, Zaanan A, Svrcek M, et al. Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2014; 46: 97-104.
- Horton KM, Fishman EK. The current status of multidetector row CT and three-dimensional imaging of the small bowel. Radiologic clinics of North America 2003; 41: 199-212.
- Kulesza J, Meszka M, Rykala C, Pawlak J. Adenocarcinoma of the small bowel - a case report. Polskiprzegladchirurgiczny 2014; 86: 285-8.
- Overman MJ, Kopetz S, Lin E, Abbruzzese JL, Wolff RA. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.Actaoncologica 2010; 49: 474-9.
Öz
Giriş: İnce bağırsağın malign tümörleri tüm gastrointestinal sistem malignitelerinin %2-3’ ünü oluşturmaktadır. İnce bağırsağın primer malignitelerinin %95’ ini adenokarsinomlar oluşturmaktadır. İleri yaşlarda sıklığı artmaktadır. Sıklıkla yerleşim yeri distal duodenum ve proksimal jejunumdur. Tanı genellikle rastlantısal olarak konulmaktadır. Cerrahi en etkin tedavi yöntemidir.
Vaka Sunumu: Bu yazıda, akut strangüle herni sebebiyle acil operasyona alınmış ve operasyon esnasında ileumda tespit edilen tümöral kitle ile ileum adenokarsinomu tanısı konulan 67 yaşında kadın hasta sunulmuştur.
Sonuç: İnce bağırsak adenokanserlerinde en etkin tedavi yöntemi cerrahidir.
Anahtar Kelimeler
Kaynakça
- Shenoy S. Primary small-bowel malignancy: update in tumor biology, markers, and management strategies. Journal of gastrointestinal cancer 2014; 45: 421-30.
- Hatzaras I, Palesty JA, Abir F, et al. Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the connecticut tumor registry. Archives of surgery 2007; 142: 229-35.
- Honda W, Ohmiya N, Hirooka Y, et al. Enteroscopic and radiologic diagnoses, treatment, and prognoses of small-bowel tumors. Gastrointestinal endoscopy 2012; 76: 344-54.
- Talamonti MS, Goetz LH, Rao S, Joehl RJ. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Archives of surgery 2002; 137: 564-70; discussion 70-1.
- Howdle PD, Jalal PK, Holmes GK, Houlston RS. Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM : monthly journal of the Association of Physicians 2003; 96: 345-53.
- Reynolds I, Healy P, McNamara DA. Malignant tumours of the small intestine. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 2014; 12: 263-70.
- Cerutti A, Rescigno M. The biology of intestinal immunoglobulin A responses. Immunity 2008; 28: 740-50.
- Sanders LM, Henderson CE, Hong MY, et al. Pro-oxidant environment of the colon compared to the small intestine may contribute to greater cancer susceptibility. Cancer letters 2004; 208: 155-61.
- Aparicio T, Zaanan A, Svrcek M, et al. Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2014; 46: 97-104.
- Horton KM, Fishman EK. The current status of multidetector row CT and three-dimensional imaging of the small bowel. Radiologic clinics of North America 2003; 41: 199-212.
- Kulesza J, Meszka M, Rykala C, Pawlak J. Adenocarcinoma of the small bowel - a case report. Polskiprzegladchirurgiczny 2014; 86: 285-8.
- Overman MJ, Kopetz S, Lin E, Abbruzzese JL, Wolff RA. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.Actaoncologica 2010; 49: 474-9.
Ayrıntılar
| Birincil Dil | İngilizce |
|---|---|
| Konular | Sağlık Kurumları Yönetimi |
| Bölüm | Vaka Sunumu (Case Report) |
| Yazarlar | |
| Yayımlanma Tarihi | 12 Ocak 2017 |
| Gönderilme Tarihi | 31 Mart 2016 |
| Kabul Tarihi | 20 Nisan 2016 |
| Yayımlandığı Sayı | Yıl 2016Cilt: 1 Sayı: 3 |
